Skip to content

Ardelyx ARDX Non-cash royalty revenue related to the sale of future royalties

Non-cash royalty revenue related to the sale of future royalties at other companies

Esperion Therapeutics logo
Esperion TherapeuticsESPR
$18.48M+76.3%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$181K-59.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$46.84M+42.0%
Xencor logo
XencorXNCR
$4.42M-75.8%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$10.9M+3.8%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$181K-59.6%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept ardx:NonCashRoyaltyRelatedToSaleOfFutureRoyalties.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's non-cash royalty revenue related to the sale of future royalties.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's non-cash royalty revenue related to the sale of future royalties?
Ardelyx (ARDX) reported non-cash royalty revenue related to the sale of future royalties of -$695K in Q1 2026.
How has Ardelyx's non-cash royalty revenue related to the sale of future royalties changed year-over-year?
Ardelyx's non-cash royalty revenue related to the sale of future royalties increased by 32.3% year-over-year, from -$1.03M to -$695K.
What does non-cash royalty revenue related to the sale of future royalties mean?
This metric captures the non-cash portion of royalty revenue recognized in relation to agreements where future royalty streams were sold upfront. It serves as an accounting adjustment to align revenue recognition with the underlying contractual obligations of the royalty monetization arrangement. It is essential for understanding the quality of earnings and the impact of financing-related revenue recognition.